Cover Image

Impact of Thrombocytopenia on In-Hospital Outcome in Patients Undergoing Percutaneous Coronary Intervention

Background. Thrombocytopenia was intuitively considered to be associated with higher risk of bleeding and multiple comorbidities after percutaneous coronary intervention (PCI). However, controversial results exist, and the real-world clinical impact of thrombocytopenia in patients undergoing PCI is...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhongxiu Chen (Author), Zheng Liu (Author), Nan Li (Author), Ran Liu (Author), Miye Wang (Author), Duolao Wang (Author), Chen Li (Author), Kai Li (Author), Fangbo Luo (Author), Yong He (Author)
Format:	Book
Published:	Hindawi-Wiley, 2021-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Simple Clinical Pre-procedure Risk Model for Predicting Thrombocytopenia Associated With Periprocedural Use of Tirofiban in Patients Undergoing Percutaneous Coronary Intervention
by: Yi-Hu Yi, et al.
Published: (2018)

Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis
by: Manyun Long, et al.
Published: (2020)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
by: Bin YANG, et al.
Published: (2018)

Factors contributing to exercise tolerance in patients with coronary artery disease undergoing percutaneous coronary intervention
by: Husheng Li, et al.
Published: (2023)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
by: Son V Pham, et al.
Published: (2010)

Predictive value of SII and sd-LDL for contrast-induced acute kidney injury in STEMI patients undergoing percutaneous coronary intervention
by: Guoqi Shen, et al.
Published: (2022)

Advanced Lung Cancer Inflammation Index for Predicting Prognostic Risk for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Wang X, et al.
Published: (2023)

Predictors and Outcomes of Secondary Prevention Medication in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
by: Tianyu Li, et al.
Published: (2021)

Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention
by: Lida Chen, et al.
Published: (2022)

Retrospective analysis of exercise capacity in patients with coronary artery disease after percutaneous coronary intervention or coronary artery bypass graft
by: Ying Li, et al.
Published: (2021)

Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: A. V. Panov
Published: (2021)

The Effect of Total Cholesterol Variability on Clinical Outcomes After Percutaneous Coronary Intervention
by: Yanting Liang, et al.
Published: (2022)

Effects of no-reflow phenomenon on ventricular systolic synchrony in patients with acute anterior myocardial infarction after percutaneous coronary intervention
by: Wang L, et al.
Published: (2016)

Comparison of Different Chronic Maintenance Antithrombotic Strategies in Patients with Coronary Artery Disease: A Systematic Review and Network Meta-Analysis
by: Junyan Zhang, et al.
Published: (2023)

Regional variations in the process of care for patients undergoing percutaneous coronary intervention in Japan
by: Satoshi Shoji, et al.
Published: (2022)

Effect of Aromatherapy Massage on Anxiety among Patients Undergoing Percutaneous Coronary Intervention
by: nasrin meshgin abadi, et al.
Published: (2012)

Discharge Hemoglobin Association with Long-Term Outcomes of ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
by: Ming Gao, et al.
Published: (2020)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)

Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention
by: Nihal El Rouby, et al.
Published: (2020)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)

IS THE SYNTAX SCORE SUFFICIENT TO ASSESS THE RISK FOR PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTIONS?
by: E. S. Novikova, et al.
Published: (2017)

The Effects of Pentoxifylline on Contrast-induced Nephropathy Reduction in Patients Undergoing Percutaneous Coronary Intervention
by: Mohammad Rouzbahani, et al.
Published: (2022)

Sex-Specific Influence of the SCARB1 Rs5888 SNP on the Serum Lipid Response to Atorvastatin in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Wu DF, et al.
Published: (2020)

Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trial
by: Ye Z, et al.
Published: (2018)

Temporal characteristics and associated factors of discontinuation and outcomes after percutaneous coronary intervention
by: Haiyan Xu, et al.
Published: (2024)

Perceptions of patients undergoing percutaneous coronary intervention on pre‐operative education in China: A qualitative study
by: Qiqi Zhuo, et al.
Published: (2021)

Interventions in reducing anxiety among patients undergoing percutaneous coronary intervention (PCI): an integrated literature review
by: Effita Piscesiana, et al.
Published: (2021)

Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
by: Runzhen Chen, et al.
Published: (2020)

Prognostic Value of Pentraxin-3 Change After Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction
by: Li SY, et al.
Published: (2023)

Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention
by: Sang-Ho Park, et al.
Published: (2015)

Renoprotective effect of remote ischemic postconditioning in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Cao B, et al.
Published: (2018)

Serum Level of Complement C1q is Associated with Contrast-Associated Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention
by: Tao J, et al.
Published: (2021)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016)

Impact of CYP2C19 variants on clinical efficacy of clopidogrel and one-year clinical outcomes in coronary heart patients undergoing percutaneous coronary intervention
by: Hong Sun, et al.
Published: (2016)

High-dose bolus tirofiban versus low-dose bolus in patients with acute coronary syndrome undergoing percutaneous coronary intervention
by: Taner Ulus, et al.
Published: (2017)

Predictors of permanent work disability among ≤50-year-old patients undergoing percutaneous coronary intervention
by: Jarmo Gunn, et al.
Published: (2015)

Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
by: Abdul Hafeez Ahmad Hamdi, et al.
Published: (2017)

The effect of the application of cold on hematoma, ecchymosis, and pain at the catheter site in patients undergoing percutaneous coronary intervention
by: Yeter Kurt, et al.
Published: (2019)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023)

Comprehensive effect of Naoxintong capsule combined with Western medicine on coronary heart disease after percutaneous coronary intervention: a meta-analysis
by: Liyuan Yu, et al.
Published: (2024)